arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1809.02032cs.AIcs.LGcs.NEq-bio.BM
收藏

靶向治疗设计的潜在分子优化

Latent Molecular Optimization for Targeted Therapeutic Design

University of Toronto(多伦多大学);Vector Institute for Artificial Intelligence(矢量人工智能研究所)

Tristan Aumentado-Armstrong

摘要:

我们设计了一种有针对性的分子设计方法,一个感兴趣的问题,在计算药物发现:给定一个目标蛋白质的网站,我们希望产生一个化学与高结合亲和力的目标和令人满意的药理学性质。这个问题是困难的潜在的治疗空间的连续性和离散性,以及生物分子表面位点的图形结构的性质。使用蛋白质-配体复合物的数据集,我们通过用图卷积网络提取目标位点的签名并将离散化学物质编码到连续的潜在向量空间中来克服这些问题。后者的嵌入允许在分子空间中基于梯度的优化,我们使用学习的结合亲和力和其他药理学特性的可微模型进行。我们表明,我们的方法能够有效地优化这些多个目标,并发现具有潜在有用的结合特性的新分子,通过对接方法进行验证。

英文摘要:

We devise an approach for targeted molecular design, a problem of interest in computational drug discovery: given a target protein site, we wish to generate a chemical with both high binding affinity to the target and satisfactory pharmacological properties. This problem is made difficult by the enormity and discreteness of the space of potential therapeutics, as well as the graph-structured nature of biomolecular surface sites. Using a dataset of protein-ligand complexes, we surmount these issues by extracting a signature of the target site with a graph convolutional network and by encoding the discrete chemical into a continuous latent vector space. The latter embedding permits gradient-based optimization in molecular space, which we perform using learned differentiable models of binding affinity and other pharmacological properties. We show that our approach is able to efficiently optimize these multiple objectives and discover new molecules with potentially useful binding properties, validated via docking methods.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑